NAICS category

Research and Development in Biotechnology (except Nanobiotechnology)

NAICS 541714

FY2026 ended Sep 30 · data still posting · data as of 2026-11-01†

† DoD contract data posts to USAspending about 90 days after award.

Part of Professional, Scientific, and Technical Services →

$2.1B
Federal awards
FY2026 · data still posting
97
Recipients
NAICS 541714
Code

NAICS code 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) accounted for $2.1B in federal contracts in FY2026, led by the Department of Health and Human Services, across 97 recipients. FY2026 ended Sep 30 and its data is still posting. Computed

Obligations by year

Computed
$2.2B
FY20
$2.6B
FY21
$2.8B
FY22
$5.1B
FY23
$3.9B
FY24
$1.5B
FY25
$2.1B
FY26 partial
▼ 30%
FY20 to FY25

Key takeaways

Computed
FY2026 ended Sep 30 · data still posting · data as of 2026-11-01
  • Research and Development in Biotechnology (except Nanobiotechnology) (NAICS 541714) accounted for $2.1B in federal obligations in FY2026, compared with $1.5B in FY2025.
  • It ranked #49 among industries by federal contract dollars in FY2026 (data still posting).
  • The Department of Health and Human Services provided 79% of it.

Top recipients

Computed

The five largest recipients on record received 38% of this category's FY2026 obligations, and the ten largest 42%.

Albert B. Sabin Vaccine Institute, Inc. (The)$266.2M
Advanced Technology International$157.2M
Shionogi Inc$156.1M
Amgen USA Inc$126M
L3Harris Technologies, Inc.$117.5M
Battelle Memorial Institute$27M
Leidos, Inc.$19.4M
Innovative Defense Technologies, LLC$14M
Trustees of Boston University$10.9M
Applied Research Associates, Inc.$10.6M

Recipient breakdown available for 49% of obligations shown

Awards

Source

Largest FY2026 awards in this category

Awards coded NAICS 541714 that started in FY2026, by the amount obligated on each so far.

AwardIDRecipientObligatedStartEndPlace
Strategic Marburg Advanced Research and Development, Preparedness, Registration…75A50126C00001Albert B. Sabin Vaccine Institute, Inc. (The)$263.6M2026-05-082036-04-30District Of Columbia
Late-Stage Development, FDA Marketing Authorization, Procurement, and Stockpile of…75A50126C00004Shionogi Inc$156.1M2026-04-062036-03-10New Jersey
Contract 75A50126C0001075A50126C00010—$96.1M2026-09-302034-12-31Virginia

Largest awards in this category

Gbi/AUR Program Management/Systems Eng
awarded 2019$4.4B
Ot Task Order 4
awarded 2023$1B
Treatment for Use in a Mass Casualty Event Where Thrombocytopenia or Platelet…
awarded 2022$839.9M
OTA Task Order 1
awarded 2023$795M
Ot Task Order 3
awarded 2023$723.5M
Procurement and Late-Stage Development of Smallpox Antiviral Drug(s)
awarded 2018$626.5M
Ot Task Order 8-RAPID Pandemic Influenza and Emerging Infectious Disease…
awarded 2024$563.7M
Clinical Services Network- Clinical Trial Planning and Execution
awarded 2023$370.1M

Total value over each award’s life, largest first.

Related

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.